FDA cleared the S-Patch CardioAI from Wellysis Corp. on Sep 25, 2026 under K254255, a traditional 510(k). The device falls under product code DPS, Electrocardiograph, regulated at 21 CFR 870.2340 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Dec 29, 2025. The decision came 270 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Wellysis Corp. in the last 12 months of the tracker.